Outcome of Board Meeting held on May 30, 2026
DBOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board approved Dhampur Bio Organics' FY26 audited results showing strong performance. Standalone revenue grew 14.4% to ₹3,106.17 crore while net profit more than doubled to ₹24.97 crore from ₹12.09 crore. The Board recommended a dividend of ₹1.50 per equity share (15%) for FY26, with record date July 17, 2026. Key leadership changes include re-designating Mr. Gautam Goel as Chairman and CEO effective May 31, 2026, and amending Articles of Association to enable MD/CEO as Chairman. The Board also approved acquisition of Sonitron Chemicals Private Limited and revised remuneration for related parties (Ms. Maayashree Goel and Ms. Meerashree Goel). Statutory and Cost Auditors were re-appointed, and the 6th AGM is scheduled for July 24, 2026. The statutory auditors issued an unmodified opinion.
The near-doubling of net profit and declaration of dividend are positive signals for shareholders. The consolidation of Chairman and CEO roles under one person strengthens executive control. The acquisition of Sonitron Chemicals signals expansion plans, though the related-party remuneration revisions will require shareholder approval.